Amiodarone Use in Cardiac Surgical Resuscitation Jeffrey R

  • Slides: 12
Download presentation
Amiodarone Use in Cardiac Surgical Resuscitation Jeffrey R. Balser, M. D. , Ph. D.

Amiodarone Use in Cardiac Surgical Resuscitation Jeffrey R. Balser, M. D. , Ph. D. Associate Professor, Anesthesiology and Pharmacology Associate Dean, Physician Scientist Development Vanderbilt University School of Medicine Nashville, TN 37232

Ventricular Arrhythmias Arrhythmia • PVCs, nonsustained VT Common Substrates normal ventricle, periop • Sustained

Ventricular Arrhythmias Arrhythmia • PVCs, nonsustained VT Common Substrates normal ventricle, periop • Sustained monomorphic VT prior MI, structural disease • Polymorphic VT with normal QT Ventricular fibrillation acute ischemia, infarction, idiopathic cardiomyopathy • Polymorphic VT with prolonged QT interval (torsade de pointes) congenital, prior drugs, low K, Mg, bradycardia

Most common sustained VT/VF in cardiac surgery • Normal QT Polymorphic VT (ischemia, hypothermia,

Most common sustained VT/VF in cardiac surgery • Normal QT Polymorphic VT (ischemia, hypothermia, infarction, ) • Ventricular Fibrillation (VF) - Little data on pharmacologic therapy for VT/VF in surgical patients… however, there are recent data in nonsurgical patients

IV Amiodarone in ICU patients • Recurrent VT/VF refractory to lidocaine, procainamide, and bretylium:

IV Amiodarone in ICU patients • Recurrent VT/VF refractory to lidocaine, procainamide, and bretylium: – 40% arrhythmia-free at 24 hrs JACC 27: 67, 1996 • After lidocaine and procainamide failure – efficacy: bretylium = amiodarone – side effects: bretylium > amiodarone Hypotension: 33% vs. 21% CHF: 5% vs. 0% Circ 92: 3255, 1995

IV Amiodarone in Cardiac Arrest 504 victims of out-of-hospital cardiac arrest in Seattle •

IV Amiodarone in Cardiac Arrest 504 victims of out-of-hospital cardiac arrest in Seattle • IV amiodarone (300 mg) or vehicle control administered by emergency personnel following 3 defibrillation attempts and 1 mg of epinephrine while CPR continued. • The likelihood of being resuscitated and being admitted to the hospital was 44% in the treatment group vs. 34% in the placebo arm (p = 0. 03) Kudenchuk et al. , N Engl J Med. 1999; 341: 871 -8

Recent Recommendations for VT/VF Management in Cardiac Arrest Airway, Breathing, etc. . Defibrillatory Shocks

Recent Recommendations for VT/VF Management in Cardiac Arrest Airway, Breathing, etc. . Defibrillatory Shocks If refractory: consider antiarrhythmic drugs amiodarone (IIb), lidocaine (Indeterminate), magnesium (IIb if hypomagnesemic state) procainamide (IIb for intermittent/recurrent VF/VT) Circulation 2000 (Aug 22), 102: I-147

Evidence-based recommendations: Terminology IIb (Amiodarone, Procainamide) • Consensus review of evidence by experts in

Evidence-based recommendations: Terminology IIb (Amiodarone, Procainamide) • Consensus review of evidence by experts in the field suggest the intervention is “Fair to Good” • Considered within “standard of care”: reasonably prudent physicians can use. • Considered optional or alternative interventions by majority of experts (versus an intervention of choice for IIa recommendation) Circulation 2000 (Aug 22), 102: I-147

Evidence-based Recommendations: shock-refractory VT/VF Lidocaine: new recommendation is “Indeterminate” Lidocaine has not been shown

Evidence-based Recommendations: shock-refractory VT/VF Lidocaine: new recommendation is “Indeterminate” Lidocaine has not been shown to be effective in treating human cardiac arrest during shock-resistant VF Circulation 2000 (Aug 22), 102: I-149

Unique Features of IV Amiodarone • No known value to combine with other agents

Unique Features of IV Amiodarone • No known value to combine with other agents - usually discontinue lidocaine, procainamide, and other antiarrhythmic agents when using IV amiodarone • Loading is empiric - 150 mg IV (rate as hemodynamically tolerated) - 2 -4 loading doses are often needed - more are not unheard of….

IV Amio in Electrical Storm Typical Scenario VF! (CPR) VF recurs (10 sec) load

IV Amio in Electrical Storm Typical Scenario VF! (CPR) VF recurs (10 sec) load IV amio (150 mg/5 -10 min) Shock VF sinus rhythm (30 sec) 6 hrs: amio sinus Shocks to 0. 5 mg/min rhythm VF recurs sinus rhythm (for now). . . reload IV amio shock VF Shock VF reload IV amio (no agent change)! 1 min later: VF recurs start amio infusion: 1 mg/min (6 hrs) sinus rhythm lasting 5 -10 min

Features of IV Amiodarone Use • Rarely chemically converts VF -maintains SR after defibrillatory

Features of IV Amiodarone Use • Rarely chemically converts VF -maintains SR after defibrillatory shocks - load, shock, SR, VF, load, shock, SR…. Sign of drug “response” may be gradual lengthening of the interval of SR between episodes of VF • Amiodarone and its solvent are both vasodilators - pressors may be needed to support BP during amiodarone loading (especially in SR)

Summary: VT/VF Pharmacologic Strategies in Cardiac Surgery • Nonsustained VT: Usually does not require

Summary: VT/VF Pharmacologic Strategies in Cardiac Surgery • Nonsustained VT: Usually does not require drug therapy • Sustained VT/VF: - Drug-induced Long QT, Torsades de Pointes: Defibrillation, then K+, Mg 2+, pacing - Other VT/VF: No controlled trials in surgical patients - data in other settings (ICU, out-of-hospital) support the use of IV amiodarone in preference to lidocaine